Vaccine Market Boost The Industry Growth USD 77.5 Billion By 2024 : Grand View Research Inc.
San Francisco, 21 July 2019 : The Report Vaccine Market Analysis By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, DNA Vaccines), By Application (Infectious Diseases, Cancer, Autism, Allergy) And Segment Forecasts To 2024 The global vaccine market valuation is expected to exceed USD 77.5 billion by 2024, according to a new report by Grand View Research, Inc. Development of various molecules to cater to the growing demand for vaccines can drive market demand. Majority of the key players are focused on vaccine development to gain an edge over competitors. For instance, Pfizer, Inc., is developing vaccines for Clostridium difficile, Staphylococcus aureus, and Meningococcal B. Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with